About Alcon
Alcon is a company based in Fort Worth (United States) founded in 1945 was acquired by Novartis in August 2010.. Alcon has raised $171.61 million across 7 funding rounds from investors including HSBC, Nestlé and Novartis. The company has 25,600 employees as of December 31, 2024. Alcon has completed 19 acquisitions, including Aerie Pharma, Aurion Biotech and BELKIN Vision. Alcon offers products and services including Clareon PanOptix Pro and Vision Care Products. Alcon operates in a competitive market with competitors including Sight Sciences, Iantrek, Keranova, Zhitong Technology and Migos Medical, among others.
- Headquarter Fort Worth, United States
- Employees 25600 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alcon Ag
-
Annual Revenue
$9.64 B (USD)2.73as on Dec 31, 2024
-
Net Profit
$989.58 M (USD)2.43as on Dec 31, 2024
-
EBITDA
$2.57 B (USD)7.91as on Dec 31, 2024
-
Total Equity Funding
$171.61 M (USD)
in 7 rounds
-
Latest Funding Round
$2 B (USD), Debt – Conventional
Sep 16, 2019
-
Investors
HSBC
& 2 more
-
Employee Count
25600
as on Dec 31, 2024
-
Investments & Acquisitions
Aerie Pharma
& 18 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Alcon
Alcon is a publicly listed company on the SIX with ticker symbol ALC in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Alcon
Alcon offers a comprehensive portfolio of products and services, including Clareon PanOptix Pro and Vision Care Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides advanced vision correction with optimal light utilization.
Offers treatments for eye health and surgical needs.
Unlock access to complete
Unlock access to complete
Software Development Team
204 people
Leadership Team
148 people
Sales and Marketing
74 people
Senior Team
64 people
Product Management Team
47 people
Human Resources and Administration
41 people
Finance and Accounting
36 people
Legal and Compliance
30 people
Unlock access to complete
Funding Insights of Alcon
Alcon has successfully raised a total of $171.61M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2 billion completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Debt – Conventional — $2.0B
-
First Round
First Round
(27 Aug 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Debt – Conventional - Alcon | Valuation |
investors |
|
| Mar, 2019 | Amount | Debt – Conventional - Alcon | Valuation |
investors |
|
| Dec, 2018 | Amount | Debt – Conventional - Alcon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alcon
Alcon has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HSBC, Nestlé and Novartis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Universal banking and financial advisory services are provided globally.
|
Founded Year | Domain | Location | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Founded Year | Domain | Location | |
|
Multi-category food and beverage products are produced and distributed globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alcon
Alcon has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Aerie Pharma, Aurion Biotech and BELKIN Vision. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Aurion Biotech is focused on developing advanced therapies for ocular diseases.
|
2021 | ||||
|
Eye drop products are offered via the official EYSUVIS website.
|
2017 | ||||
|
Laser device for glaucoma treatment developed by BELKIN Vision.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Alcon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alcon Comparisons
Competitors of Alcon
Alcon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sight Sciences, Iantrek, Keranova, Zhitong Technology and Migos Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Surgical systems for ophthalmological disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a minimally invasive eye surgery technology
|
|
| domain | founded_year | HQ Location |
Surgical equipment for anterior chamber ophthalmic surgery is developed.
|
|
| domain | founded_year | HQ Location |
Developer of surgical devices for ophthalmic indications
|
|
| domain | founded_year | HQ Location |
Minimally invasive ophthalmology devices for glaucoma are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alcon
Frequently Asked Questions about Alcon
When was Alcon founded?
Alcon was founded in 1945 and raised its 1st funding round 65 years after it was founded.
Where is Alcon located?
Alcon is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.
Who is the current CEO of Alcon?
David Endicott is the current CEO of Alcon.
Is Alcon a funded company?
Alcon is a funded company, having raised a total of $171.61M across 7 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $3.79M, raised on Aug 27, 2010.
How many employees does Alcon have?
As of Dec 31, 2024, the latest employee count at Alcon is 25,600.
What is the annual revenue of Alcon?
Annual revenue of Alcon is $9.64B as on Dec 31, 2024.
What does Alcon do?
Alcon was founded in 1945 and is headquartered in Fort Worth, United States. Operations focus on the medical technology sector, where pharmaceuticals, surgical equipment, and devices are developed, manufactured, and marketed. Contact lens solutions and other vision care products are also produced to address eye diseases, disorders, and conditions. The company serves global markets through these specialized offerings.
Who are the top competitors of Alcon?
Alcon's top competitors include Sight Sciences, Iantrek and Keranova.
What products or services does Alcon offer?
Alcon offers Clareon PanOptix Pro and Vision Care Products.
Is Alcon publicly traded?
Yes, Alcon is publicly traded on SIX under the ticker symbol ALC.
How many acquisitions has Alcon made?
Alcon has made 19 acquisitions, including Aerie Pharma, Aurion Biotech, and BELKIN Vision.
What is Alcon's ticker symbol?
The ticker symbol of Alcon is ALC on SIX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.